FDA Inspection 985159 — Versiti Indiana Inc
The FDA completed an inspection of Versiti Indiana Inc on Sep 21, 2016 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 21, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dayton, OH (United States)